Ledger.Open graph →

SEC Form D · Amendment · filed September 15, 2015

Pronutria Biosciences, Inc

Offering

—

Sold

$39.3M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

CAMBRIDGE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

John B. Mendlein · CAMBRIDGE, MADirector Robert Connelly · CAMBRIDGE, MAExec · Director Jeff B. Moore · CAMBRIDGE, MAExec Gary B. Pisano · CAMBRIDGE, MADirector David Berry · CAMBRIDGE, MADirector Peter B. Hutt · CAMBRIDGE, MADirector Charles Cooney · CAMBRIDGE, MADirector Stephen Hoge · CAMBRIDGE, MADirector Noubar Afeyan · CAMBRIDGE, MADirector Andrew Smith · Philadelphia, PAExec Jeffrey L. Cotton · Philadelphia, PADirector Christopher Edwards · Philadelphia, PADirector Marika Tooze · Philadelphia, PAExec · Director Susan Mullin · Philadelphia, PADirector Jennifer A. Nichols · Philadelphia, PADirector Richard Fonash · Philadelphia, PAExec · Director Alan R. Goodson · Philadelphia, PADirector Frank S. Ioppolo · Lake Mary, FLDirector Eugene D. James · NEW YORK, NYDirector Charles Ayres · NEW YORK, NYDirector Christopher R. Manning · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗